Hercules Capital Provides $100MM Credit Facility to G1 Therapeutics
Hercules Capital entered into a $100 million debt financing agreement with G1 Therapeutics, a clinical-stage oncology company. G1 plans to use the proceeds to fund commercialization and further development of trilaciclib.
June 2, 2020
Armentum Partners | Bryan Jadot | G1 Therapeutics | Hercules Capital | Mark Velleca
Phil Neuffer